Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Nov;76(3 Suppl 3):73–78. doi: 10.1136/hrt.76.3_suppl_3.73

Inhibition of the renin-angiotensin system after acute myocardial infarction—treat first, select later?

Alistair S Hall 1, Rob Sapsford 1, Simon G Megarry 1, Stephen G Ball 1
PMCID: PMC484492  PMID: 8977366

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med. 1995 Jan 12;332(2):80–85. doi: 10.1056/NEJM199501123320203. [DOI] [PubMed] [Google Scholar]
  2. Collins R., Julian D. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. Br Heart J. 1991 Sep;66(3):250–255. doi: 10.1136/hrt.66.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. De Graeff P. A., Van Gilst W. H., De Langen C. D., Kingma J. H., Wesseling H. Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heart. Arch Int Pharmacodyn Ther. 1986 Apr;280(2):181–193. [PubMed] [Google Scholar]
  4. De Vita C., Franzosi M. G., Geraci E., Maggioni A. P., Mauri F., Mezzanotte G., Tavazzi L., Tognoni G., Volpi A. GISSI-2: mortality plus extensive left-ventricular damage as "end-point". Lancet. 1990 Feb 3;335(8684):289–289. doi: 10.1016/0140-6736(90)90104-d. [DOI] [PubMed] [Google Scholar]
  5. Furberg C. D., Campbell R. W., Pitt B. ACE inhibitors after myocardial infarction. N Engl J Med. 1993 Apr 1;328(13):967–969. [PubMed] [Google Scholar]
  6. Furberg C. D., Yusuf S. Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol. 1985 Apr 1;55(8):1110–1113. doi: 10.1016/0002-9149(85)90756-8. [DOI] [PubMed] [Google Scholar]
  7. Ganley C. J., Hung H. M., Temple R. More on the survival and ventricular enlargement trial. N Engl J Med. 1993 Oct 14;329(16):1204–1206. doi: 10.1056/nejm199310143291616. [DOI] [PubMed] [Google Scholar]
  8. Hall A. S., Ball S. G. Clinical background to the use of ACE inhibitor therapy after myocardial infarction. J Cardiovasc Risk. 1995 Oct;2(5):396–405. doi: 10.1177/174182679500200503. [DOI] [PubMed] [Google Scholar]
  9. Hall A. S., Tan L. B., Ball S. G. Inhibition of ACE/kininase-II, acute myocardial infarction, and survival. Cardiovasc Res. 1994 Feb;28(2):190–198. doi: 10.1093/cvr/28.2.190. [DOI] [PubMed] [Google Scholar]
  10. Kleist P. ACE inhibitors after myocardial infarction. Lancet. 1994 Jun 25;343(8913):1633–1634. [PubMed] [Google Scholar]
  11. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  12. Pfeffer M. A., Lamas G. A., Vaughan D. E., Parisi A. F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988 Jul 14;319(2):80–86. doi: 10.1056/NEJM198807143190204. [DOI] [PubMed] [Google Scholar]
  13. Pfeffer M. A., Pfeffer J. M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985 Aug;72(2):406–412. doi: 10.1161/01.cir.72.2.406. [DOI] [PubMed] [Google Scholar]
  14. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
  15. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  16. Van Gilst W. H., De Graeff P. A., Kingma J. H., Wesseling H., De Langen C. D. Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion. Eur J Pharmacol. 1984 Apr 13;100(1):113–117. doi: 10.1016/0014-2999(84)90323-6. [DOI] [PubMed] [Google Scholar]
  17. Weisman H. F., Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987 Sep-Oct;30(2):73–110. doi: 10.1016/0033-0620(87)90004-1. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES